跳至主要内容
临床试验/NCT07126015
NCT07126015尚未招募不适用

Predicting Biological Therapy Effectiveness in Ulcerative Colitis Patients Using Intestinal Ultrasound and Visceral Fat Assessment: A Prospective Study

Assiut University0 个研究点目标入组 200 人开始时间: 2026年1月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
200
主要终点
Change in Visceral Adipose Tissue Volume Measured by abdominal and pelvic CT examination from Baseline to month 6

研究概览

简要总结

Our study aimed to detecting biological therapy effectiveness in UC patients using visceral fat assessment

详细描述

Ulcerative colitis (UC) has a relapsing-remitting course which necessitates frequent follow-up examinations to monitor disease activity.

Disease management was previously guided by patient reported symptoms, and treatment targets were based on symptom control. However, the patient's symptoms do not necessarily correspond to inflammatory activity and current guidelines recommend that management should be based on objective evaluations.

Gastrointestinal ultrasound [GIUS] has high diagnostic accuracy for detecting active CD, and in trained hands, it can make significant impact on clinical decision-making.

Furthermore, as it is non-invasive, readily available and can be performed bedside, the modality seems well suited for bedside and frequent activity monitoring.

UC is often associated with underweight (BMI < 18 kg/m2); however, numerous studies find overweight and obesity also common.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Any patient above age of 18 years old and diagnosed to have active UC through
  • Clinical features: rectal bleeding, with frequent stools and mucous discharge from the rectum. Some patients also describe tenesmus. The onset is typically insidious.
  • Endoscopic findings include the following; loss of vascular pattern, Granular and fragile mucosa, friability, ulcerations, erosions, pseudo-polyposis.

排除标准

  • Patients with UC who are under age of 18 years old.
  • Pregnancy.
  • Previous colectomy.
  • Patient refuse to participate in the study

结局指标

主要结局

Change in Visceral Adipose Tissue Volume Measured by abdominal and pelvic CT examination from Baseline to month 6

时间窗: Baseline (pre-treatment) and after induction dose (typically 6 month post-initiation of biological therapy) by abdominal and pelvic CT examination

Effectiveness of Biological Therapy in UC Patients Based on Changes in Visceral Adipose Tissue (VAT) by abdominal and pelvic CT examination

时间窗: Baseline (pre-treatment) and after induction dose (typically 6 month post-initiation of biological therapy)

Change in visceral fat volume and distribution as assessed by abdominal and pelvic CT examination before and after the induction phase of biological therapy in patients with ulcerative colitis. CT scans will be analyzed to determine the relationship between VAT and treatment response, considering clinical and endoscopic outcomes.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amira Mohammed Abdel Mowgod

Lecturer of Tropical Medicine and Gastroenterology

Assiut University

相似试验